{"id":4861,"date":"2023-08-04T07:37:48","date_gmt":"2023-08-04T11:37:48","guid":{"rendered":"https:\/\/www.arxresearch.com\/?post_type=product&#038;p=4861"},"modified":"2023-08-04T07:41:33","modified_gmt":"2023-08-04T11:41:33","slug":"fair-market-value-compensation-rates-for-oncology-kols-ireland","status":"publish","type":"product","link":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/","title":{"rendered":"Fair-Market Value Compensation Rates for Oncology KOLs &#8211; Ireland"},"content":{"rendered":"<p>KOL FMV Rates Oncology Ireland presents fair-market value compensation rates for Irish-based KOLs in oncology, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national, and local).<\/p>\n<p>These defensible market-based rate data are built directly from industry compensation paid to Healthcare Practitioners (HCPs) and Thought Leaders (KOLs). All KOL FMV rates reports represent fair-market value established using our reliable methodology of collecting data from industry professionals involved in defining compensation levels for exchanges with KOLs worldwide.<\/p>\n<p>Establishing fair-market value compensation rates will:<\/p>\n<ul>\n<li>reduce the external perception of inappropriate inducement and limit regulatory and compliance risks.<\/li>\n<li>provide an independent reference for negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs).<\/li>\n<li>refine and support the development of fee schedules aligned with market conditions.<\/li>\n<li>competitively position the organization and support good business practices.<\/li>\n<\/ul>\n<p>The data included in each report are an aggregate of collected data and not individual rates. In no event, companies and individuals who provided the data are identified to protect their identity.<\/p>\n<p>Payments made to physicians and thought leaders have been under scrutiny for a few years. Companies are now working more than ever to adjust their rates to level with industry standards.<\/p>\n<p>Adjustments to market rates should be made periodically and are best done through 3rd party research, providing a fair and balanced assessment of rates. These payment benchmarks have proved to help legal, compliance, and Medical Affairs executives establish sound working relationships with Thought Leaders and Healthcare Professionals.<\/p>\n<p>KOL FMV Rates Oncology Ireland &#8211; <a href=\"https:\/\/medical-dictionary.thefreedictionary.com\/oncology\">oncology definition<\/a><\/p>\n<p>Nothing in this study constitutes financial or legal advice. We provide the contents of the study for information purposes only. This study may not be lent, resold, hired out, or otherwise disposed of by way of trade in any form of binding or cover other than that in which it is published, without the prior written consent of Arx Research.<\/p>\n<p>INSIGHT<\/p>\n<p>Research shows that less than 25% of pharmaceutical organizations begin working and involving Key Opinion Leaders during or before clinical phases. Most \u2013 63% \u2013 wait during phases 2 and 3 to start exchanging with Thought Leaders. Read on here <a href=\"https:\/\/www.arxresearch.com\/kol-lifecycle-involvement\/\">KOL lifecycle involvement (arxresearch.com)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>KOL FMV Rates Oncology Ireland presents hourly and half-day flat compensation rate cards for four (4) Thought Leader levels based on degree of influence. The data is presented by percentiles and outlines representative input directly from industry professionals involved in defining compensation levels for exchanges with KOLs.<\/p>\n<p>Number of pages: 8<br \/>\nFormat: Downloadable PDF<br \/>\nPublished: 2023<\/p>\n<p><strong>Price: Single-user $525 \/ Multi-users $990<\/strong><\/p>\n","protected":false},"featured_media":4864,"template":"","meta":[],"product_cat":[131],"product_tag":[155,133,132,134,286,135,136,142,140,141,138,137],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>KOL FMV Rates Oncology Ireland<\/title>\n<meta name=\"description\" content=\"This report provides FMV compensation rates for Irish-based Thought Leaders (KOLs) in Oncology (KOL FMV Rates Oncology Ireland).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KOL FMV Rates Oncology Ireland\" \/>\n<meta property=\"og:description\" content=\"This report provides FMV compensation rates for Irish-based Thought Leaders (KOLs) in Oncology (KOL FMV Rates Oncology Ireland).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/\" \/>\n<meta property=\"og:site_name\" content=\"Arx Research\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-04T11:41:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"375\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/\",\"url\":\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/\",\"name\":\"KOL FMV Rates Oncology Ireland\",\"isPartOf\":{\"@id\":\"https:\/\/www.arxresearch.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png\",\"datePublished\":\"2023-08-04T11:37:48+00:00\",\"dateModified\":\"2023-08-04T11:41:33+00:00\",\"description\":\"This report provides FMV compensation rates for Irish-based Thought Leaders (KOLs) in Oncology (KOL FMV Rates Oncology Ireland).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#primaryimage\",\"url\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png\",\"contentUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png\",\"width\":500,\"height\":375,\"caption\":\"KOL FMV Rates Oncology Ireland\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arxresearch.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reports\",\"item\":\"https:\/\/www.arxresearch.com\/reports\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Fair-Market Value Compensation Rates for Oncology KOLs &#8211; Ireland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arxresearch.com\/#website\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"name\":\"Arx Research\",\"description\":\"Medical Affairs Benchmarking\",\"publisher\":{\"@id\":\"https:\/\/www.arxresearch.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arxresearch.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arxresearch.com\/#organization\",\"name\":\"Arx Research\",\"url\":\"https:\/\/www.arxresearch.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"contentUrl\":\"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png\",\"width\":217,\"height\":100,\"caption\":\"Arx Research\"},\"image\":{\"@id\":\"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/arx-research\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KOL FMV Rates Oncology Ireland","description":"This report provides FMV compensation rates for Irish-based Thought Leaders (KOLs) in Oncology (KOL FMV Rates Oncology Ireland).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/","og_locale":"en_US","og_type":"article","og_title":"KOL FMV Rates Oncology Ireland","og_description":"This report provides FMV compensation rates for Irish-based Thought Leaders (KOLs) in Oncology (KOL FMV Rates Oncology Ireland).","og_url":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/","og_site_name":"Arx Research","article_modified_time":"2023-08-04T11:41:33+00:00","og_image":[{"width":500,"height":375,"url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png","type":"image\/png"}],"twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/","url":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/","name":"KOL FMV Rates Oncology Ireland","isPartOf":{"@id":"https:\/\/www.arxresearch.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#primaryimage"},"image":{"@id":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png","datePublished":"2023-08-04T11:37:48+00:00","dateModified":"2023-08-04T11:41:33+00:00","description":"This report provides FMV compensation rates for Irish-based Thought Leaders (KOLs) in Oncology (KOL FMV Rates Oncology Ireland).","breadcrumb":{"@id":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#primaryimage","url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png","contentUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/819-IRL-ONCO.png","width":500,"height":375,"caption":"KOL FMV Rates Oncology Ireland"},{"@type":"BreadcrumbList","@id":"https:\/\/www.arxresearch.com\/reports\/fair-market-value-compensation-rates-for-oncology-kols-ireland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arxresearch.com\/"},{"@type":"ListItem","position":2,"name":"Reports","item":"https:\/\/www.arxresearch.com\/reports\/"},{"@type":"ListItem","position":3,"name":"Fair-Market Value Compensation Rates for Oncology KOLs &#8211; Ireland"}]},{"@type":"WebSite","@id":"https:\/\/www.arxresearch.com\/#website","url":"https:\/\/www.arxresearch.com\/","name":"Arx Research","description":"Medical Affairs Benchmarking","publisher":{"@id":"https:\/\/www.arxresearch.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arxresearch.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arxresearch.com\/#organization","name":"Arx Research","url":"https:\/\/www.arxresearch.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","contentUrl":"https:\/\/www.arxresearch.com\/wp-content\/uploads\/2015\/08\/arx-logo-left-web.png","width":217,"height":100,"caption":"Arx Research"},"image":{"@id":"https:\/\/www.arxresearch.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/arx-research"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product\/4861"}],"collection":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/media\/4864"}],"wp:attachment":[{"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/media?parent=4861"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_cat?post=4861"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.arxresearch.com\/wp-json\/wp\/v2\/product_tag?post=4861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}